To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Idursulfase Approved in Brazil for Treatment of Hunter Syndrome URL: http://www.pslgroup.com/dg/2224F6.htm Doctor's Guide May 27, 2008
CAMBRIDGE, Mass -- May 27, 2008 -- The Brazilian Regulatory Agency, Agência Nacional de Vigilância Sanitária, has approved idursulfase (ELAPRASE), a human enzyme-replacement therapy for the treatment of Hunter syndrome. Idursulfase is developed by Shire Human Genetic Therapies, a business unit of Shire focused on genetic diseases, and is the first and only enzyme-replacement therapy approved for people suffering from Hunter syndrome. With this approval, idursulfase is now cleared for marketing in 2 countries in the region: Brazil and Mexico. Idursulfase was approved in the United States in July 2006 and is approved for use in 40 countries. Idursulfase, which is given as a weekly infusion, is designed to replace the deficient iduronate-2-sulfatase enzyme demonstrated in patients with Hunter syndrome. "This is a tremendous milestone for the many Hunter syndrome patients in Brazil, who will now have access to treatment for this serious and life-threatening disease," said Professor Roberto Giugliani, MD, PhD, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. "With [idursulfase], physicians will now be able to move patients beyond palliative care and provide specific treatment for Hunter syndrome." SOURCE: Shire Limited --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.